Evidence map›Paper›PMID 35965500›Full record

ArticleFrontiers in oncology2022

WNT4 overexpression and secretion in thymic epithelial tumors drive an autocrine loop in tumor cells

Xiaonan Zhang, Berthold Schalke, Krisztian Kvell, Katharina Kriegsmann, Mark Kriegsmann, Thomas Graeter, Gerhard Preissler, German Ott, Katrin Kurz, Elena Bulut and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 2 countries.

Xiaonan ZhangInstitute of Pathology and Medical Research Center, University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany.
Berthold SchalkeDepartment of Neurology, University of Regensburg, Regensburg, Germany.
Krisztian KvellDepartment of Pharmaceutical Biotechnology, Faculty of Pharmacy, University of Pecs, Pecs, Hungary.
Katharina KriegsmannDepartment of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
Mark KriegsmannTranslational Lung Research Centre Heidelberg, German Centre for Lung Research, Heidelberg, Germany.
Thomas GraeterDepartment of Thoracic Surgery, University Medical Centre Erlangen, Erlangen, Germany.
Gerhard PreisslerDepartment of Thoraxic Surgery, Clinic Schillerhöhe, Robert-Bosch-Hospital, Gerlingen, Löwenstein, Germany.
German OttDepartment of Clinical Pathology, Robert-Bosch-Hospital, Stuttgart, Germany.
Katrin KurzDepartment of Clinical Pathology, Robert-Bosch-Hospital, Stuttgart, Germany.
Elena BulutDepartment of Thoraxic Surgery, Thoraxklinik at Heidelberg University Hospital, Heidelberg, Germany.
Philipp StröbelInstitute of Pathology, University Medical Center Göttingen, University of Göttingen, Göttingen, Germany.
Alexander MarxInstitute of Pathology and Medical Research Center, University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany.
Djeda BelharazemInstitute of Pathology and Medical Research Center, University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany.
Heidelberg University · DERobert Bosch Hospital · DEDr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology · DEUniversitätsklinikum Erlangen · DEUniversitätsmedizin Göttingen · DEUniversity Hospital Heidelberg · DEUniversity Medical Centre Mannheim · DEUniversity of Pecs · HUUniversity of Regensburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: WNT4-driven non-canonical signaling is crucial for homeostasis and age-related involution of the thymus. Abnormal WNT signaling is important in many cancers, but the role of WNT signaling in thymic tumors is largely unknown. Materials & Methods: Expression and function of WNT4 and FZD6 were analyzed using qRT-PCR, Western blot, ELISA, in biopsies of non-neoplastic thymi (NT), thymoma and thymic carcinomas. ShRNA techniques and functional assays were used in primary thymic epithelial cells (pTECs) and TC cell line 1889c. Cells were conventionally (2D) grown and in three-dimensional (3D) spheroids. Results: In biopsy, WHO classified B3 thymomas and TCs showed increased WNT4 expression compared with NTs. During short-term 2D culture, WNT4 expression and secretion declined in neoplastic pTECs but not in 3D spheroids or medium supplemented with recombinant WNT4 cultures. Under the latter condition, the growth of pTECs was accompanied by increased expression of non-canonical targets RAC1 and JNK. Down-regulation of WNT4 by shRNA induced cell death in pTECs derived from B3 thymomas and led to decreased RAC1, but not JNK protein phosphorylation. Pharmacological inhibition of NF-κB decreased both RAC1 and JNK phosphorylation in neoplastic pTECs. Conclusions: Lack of the age-related decline of non-canonical WNT4 expression in TETs and restoration of declining WNT4 expression through exogeneous WNT4 or 3D culture of pTECs hints at an oncogenic role of WNT4 in TETs and is compatible with the WNT4 autocrine loop model. Crosstalk between WNT4 and NF-κB signaling may present a promising target for combined interventions in TETs.

Indexed as

JNKNF-κB and AKT noncanonical pathwayprimary epithelial cellsthymic carcinomathymomaWNT4/FZD6

Identifiers

PMID35965500
PMCPMC9372913
OpenAlexW4288535516

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.